What will be the effects of implementing the (New guideline defining blood pressure) in Iran
Perhaps it is because of growing concern about this statistic that the definition of hypertension recommended in The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure / (JNC7) which is widely used among general practitioners and specialists, has been changed in The 2017 American Heart Association (AHA) and American College of Cardiology (ACC) guidelines and decreased normal level of hypertension from
Huge global variation in oesophageal cancer incidence not due to a unique pattern of DNA damage
Major global research collaboration adds new piece to the complex puzzle of oesophageal cancer.
Cancer in Iran 2008 to 2025: recent incidence trends and short-term predictions of the future burden
A new article examines recent cancer incidence trends in the Islamic Republic of Iran and presents predicted incidence rates and numbers of new cases for the entire country for the year 2025.
After two decades of research efforts by Iranian scientists in the Golestan Cohort Study
Carcinogenicity of Opium Consumption was confirmed by the International Agency for Research on Cancer
At an important historical event , Carcinogenicity of Opium Consumption , the most prominent achievement of more than two decades of research efforts of Iranian scientists in the "Golestan Cohort Study " was published in Volume 126 of the Monographs of the International Agency for Research on Cancer of the World Health Organization (IARC)
The researchers of the Digestive Diseases Research Institute proved for the first time in the world
The possibility of prophylaxis of acute pancreatitis in ERCP without pancreatic duct stenting
The researchers of the Digestive Diseases Research Institute of Tehran University of Medical Science, in a study proved for the first time in the world that Pharmacological prophylaxis of acute pancreatitis in ERCP alone is sufficient and does not require "pancreatic duct stenting with Pharmacological prophylaxis " in patients at risk